Endo, Inc. (NDOI)
OTCMKTS
· Delayed Price · Currency is USD
20.90
0.00 (0.00%)
Jun 23, 2025, 4:00 PM EDT
Endo, Inc. Revenue
Endo, Inc. had revenue of $392.83M in the quarter ending March 31, 2025, a decrease of -6.36%. This brings the company's revenue in the last twelve months to $1.73B, down -9.52% year-over-year. In the year 2024, Endo, Inc. had annual revenue of $1.76B, down -12.50%.
Revenue (ttm)
1.73B
Revenue Growth
-9.52%
P/S Ratio
0.92
Revenue / Employee
556.31K
Employees
3,116
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.76B | -251.38M | -12.50% |
| Dec 31, 2023 | 2.01B | -307.36M | -13.25% |
| Dec 31, 2022 | 2.32B | -674.33M | -22.53% |
| Dec 31, 2021 | 2.99B | 90.13M | 3.10% |
| Dec 31, 2020 | 2.90B | -11.29M | -0.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
Endo, Inc. News
- 6 days ago - Endo Completes International Pharmaceuticals Business Divestiture - PRNewsWire
- 10 days ago - Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader - PRNewsWire
- 14 days ago - Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company - PRNewsWire
- 21 days ago - Endo Champions Men's Health Month with Education, Awareness, and Outreach - PRNewsWire
- 5 weeks ago - ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI - Business Wire
- 5 weeks ago - Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration - PRNewsWire
- 5 weeks ago - Mallinckrodt and Endo Announce Significant Progress in Proposed Merger - PRNewsWire
- 6 weeks ago - Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance - PRNewsWire